Skip to content
★ Sign in to follow
BM

BrainAurora Medical Technology Ltd. - B Stock: price and insider trades · Hong Kong

HK·Mcap HK$994.3MHealth Care

No insider purchase over the last 90 days. The latest, by TAN Zheng, was filed 30 Jun 2026.

BrainAurora Medical Technology Ltd. - B: what insiders have been doing

BrainAurora Medical Technology Ltd. - B belongs to the Health Care sector. Filings by its managers are published through HKEX. In the past year (22 October 2025 to 22 October 2026), 27 filings came from 2 insiders.

Both sides are active: 15 purchases worth €58.2M and 7 sales worth €84.5M, from 1 insider and 2 insiders respectively. The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. At €55.9M, the purchase published on 10 February 2026 by TAN Zheng is the largest of the period. Those buying include 1 senior executive.

Compared with its exchange (1,314 companies, median 4 filings), a count of 27 filings is above the norm. Over the whole record (from 2026), the tally stands at 15 purchases and 7 sales.

The most recent open-market purchase was published on 30 June 2026, 131 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 3 days. That lag is the time during which only the insider knows about the trade.

Elsewhere in the same sector, our signals recently picked up insider purchases at UCB. Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
27
Thresholds
n/a
Buy Volume
€58M
15 ops. · all time
Sell Volume
€84M
7 ops. · all time

Who traded when

BuySale
TAN Zheng15 buys6 sales
Li Mingqiu1 sale

Since the insiders bought

  • Filed 30 Jun 2026 · 131 days ago · €56k
    -57.5%
    Entry HK$1.79 · Close 21 Oct 2026 HK$0.76

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 24,097 of 26,897 companies
22.2
score / 100
Value
12
Quality
33
FCF yld-15%
Earn yld-22%
EV/EBITDA·
ROE-98%
Gross mgn41%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.77
Analyst consensus
1 analysts
·
HK$8.03Target HK$8.03(+950%)HK$8.03
Income statement
RevenueHK$220M
Gross profitHK$89.5M41% margin
EBITDA-HK$266.1M-121% margin
Net income-HK$314.9M-134.4% margin
Valuation
P/Book2.1x
Balance sheet & cash
Market capHK$994.3M
Total debtHK$565.5M
Free Cash Flow-HK$205.7M
Debt / Equity133%
Profitability & ownership
ROE-97.7%
ROA-19.9%
% insiders57.8%
% institutions9.6%
Last declaration on 30 June 2026
Declarations27 total
  • ▲
    DirectorExecutives
    501,000 HKD11HKEX
    300,000 shares@ HK$1.670.021% mcap2.4% of flowShareXHKGHKEX:DA20260630E00092
    Canonical exit: 24 Sept 2026 (T+90)
  • ▲
    DirectorExecutives
    1M HKD12HKEX
    500,000 shares@ HK$2.50680.063% mcap5.9% of flowShareXHKGHKEX:DA20260610E00034
    Canonical exit: 6 Sept 2026 (T+90)
  • ▲
    DirectorExecutives
    263,530 HKD11HKEX
    100,000 shares@ HK$2.63530.011% mcap1.2% of flowShareXHKGHKEX:DA20260601E00210
    Canonical exit: 27 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    267,000 HKD11HKEX
    100,000 shares@ HK$2.670.013% mcap1.2% of flowShareXHKGHKEX:DA20260528E00026
    Canonical exit: 25 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    1M HKD12HKEX
    500,000 shares@ HK$2.86840.071% mcap6.7% of flowShareXHKGHKEX:DA20260528E00025
    Canonical exit: 24 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    9M HKD15HKEX
    3,000,000 shares@ HK$3.02510.45% mcap42.4% of flowShareXHKGHKEX:DA20260522E00176
    Canonical exit: 19 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD12HKEX
    500,000 shares@ HK$3.78150.075% mcap8.8% of flowShareXHKGHKEX:DA20260513E00191
    Canonical exit: 10 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    570,000 HKD11HKEX
    150,000 shares@ HK$3.800.023% mcap2.6% of flowShareXHKGHKEX:DA20260507E00024
    Canonical exit: 3 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD12HKEX
    549,000 shares@ HK$3.94110.086% mcap10.1% of flowShareXHKGHKEX:DA20260507E00021
    Canonical exit: 2 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    757,000 HKD11HKEX
    200,000 shares@ HK$3.7850.030% mcap3.5% of flowShareXHKGHKEX:DA20260430E00351
    Canonical exit: 29 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    376,819 HKD11HKEX
    96,000 shares@ HK$3.92520.015% mcap1.7% of flowShareXHKGHKEX:DA20260428E00292
    Canonical exit: 26 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    793,420 HKD11HKEX
    200,000 shares@ HK$3.96710.031% mcap3.7% of flowShareXHKGHKEX:DA20260428E00290
    Canonical exit: 23 Jul 2026 (T+90)
  • ▼
    Executives
    0HKEX
    123,527,000 sharesShareXHKGHKEX:DA20260424E00670
  • ▲
    DirectorExecutives
    425,059 HKD2HKEX
    101,000 shares@ HK$4.20850.017% mcap2.0% of flowShareXHKGHKEX:DA20260421E00441
    Canonical exit: 15 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    2M HKD3HKEX
    403,000 shares@ HK$4.15790.066% mcap7.7% of flowShareXHKGHKEX:DA20260421E00444
    Canonical exit: 16 Jul 2026 (T+90)
  • ▼
    DirectorExecutives
    0HKEX
    59,104,000 sharesShareXHKGHKEX:DA20260211E00294
  • ▲
    DirectorExecutives
    515M HKD15HKEX
    92,000,000 shares@ HK$5.6039.2% of flowShareXHKGHKEX:DA20260210E00403
    Canonical exit: 6 May 2026 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    92,000,000 sharesShareXHKGHKEX:DA20260128E00535
  • ▼
    DirectorExecutives
    515M HKD15HKEX
    92,000,000 shares@ HK$5.6039.0% of flowShareXHKGHKEX:DA20260128E00537
  • ▼
    DirectorExecutives
    49M HKD11HKEX
    8,000,000 shares@ HK$6.173.8% of flowShareXHKGHKEX:DA20260120E00524
  • ●
    DirectorExecutives
    0HKEX
    8,000,000 sharesShareXHKGHKEX:DA20260119E00686
  • ▼
    DirectorExecutives
    52M HKD11HKEX
    8,000,000 shares@ HK$6.494.0% of flowShareXHKGHKEX:DA20260119E00684
  • ●
    DirectorExecutives
    0HKEX
    8,000,000 sharesShareXHKGHKEX:DA20260116E00628
  • ▼
    DirectorExecutives
    107M HKD12HKEX
    16,000,000 shares@ HK$6.678.2% of flowShareXHKGHKEX:DA20260116E00627
  • ●
    DirectorExecutives
    0HKEX
    16,000,000 sharesShareXHKGHKEX:DA20260115E00546

25 of 27 declarations

About BrainAurora Medical Technology Ltd. - B

BrainAurora Medical Technology Ltd. is a company focused on developing innovative medical technologies. It operates in the healthcare and pharmaceutical sector in Hong Kong.